Park Ha Biological Technology is trading 7.4% down at $0.39 today amid a broader sell-off in the biotech and high-growth tech sectors.

  • The decline is part of a continued downward trend from a high of $0.73 over the past week.
  • The move is driven by a risk-off market environment impacting the XBI biotech ETF and major indices.
  • No company-specific news has been released today to account for the current price action.